All Upcoming Events

Join AsymBio’s live webinar to uncover the process challenges that can stand between an ADC and commercialization—and explore cutting-edge conjugation technologies with insights drawn from extensive hands-on experience.

Join us for an insightful webinar to see how iTraX™ Chemistry helps discovery teams to manage multiple collaborators securely and efficiently within a single project.

You’re invited to a roundtable discussion on October 29 from 7:30-9am at the Ritz-Carlton Boston on early-phase oncology research.

Join the live webinar to explore how fit-for-purpose MS strategies help confirm molecular identity, identify structural liabilities, and characterize in vivo exposure and molecular integrity. Through real-world case studies spanning mAbs, bispecifics, and ADCs, learn how MS enables rapid confirmation, candidate triage, unlock structure-function relationships with in vivo insights.

Patient to Endpoint: Diagnostics and Data to Accelerate Clinical Trials

You’re invited to an early-phase oncology research panel discussion on “From First Dose to First Data: Lessons Learned at the Milestones That Matter.”

In this webinar, we will show how delayed isolation and cryopreservation of immune cells from fresh leukopaks can drastically impact their stability and functionality. We will also explore how purified and cryopreserved cell populations such as PBMCs and isolated T cells streamline logistics, reduce variability, and enhance transduction efficiency in CAR-T production.

The 20th Annual Personalized Medicine Conference brings together leaders from industry, research, policy, and patient advocacy to explore advances in personalized medicine and discuss how to translate scientific progress into better patient care.

Join an exclusive community of West Coast CFOs, Controllers, and senior finance leaders from emerging and commercial-stage life sciences organizations for two focused days on the challenges defining biotech finance today.

This year tested many of the assumptions underpinning biotech forecasts. While analysts correctly identified several emerging trends, ongoing capital constraints, widening capability gaps and the growing importance of global development revealed a more complex reality than many expected. This webinar explores which predictions proved most accurate, where expectations diverged from market conditions and what those outcomes can teach leaders planning for 2027.

Join nearly 3,500 scientists from across the world at ISSCR 2027 for a 4-day event highlighting the most important breakthroughs in stem cell research and regenerative medicine.